Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?

被引:359
作者
Cappelletti, Simone [1 ]
Daria, Piacentino [2 ]
Sani, Gabriele [2 ]
Aromatario, Mariarosaria [1 ]
机构
[1] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Sch Med & Psychol, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, I-00161 Rome, Italy
关键词
Abuse; caffeine; coffee; dependence; energy drinks; safety doses; toxicity; ENERGY DRINK CONSUMPTION; ADENOSINE A(2A) RECEPTOR; BLOOD-PRESSURE; COFFEE CONSUMPTION; PARKINSONS-DISEASE; MEMORY IMPAIRMENT; DIETARY CAFFEINE; HEART-DISEASE; SHORT-TERM; RAT MODEL;
D O I
10.2174/1570159X13666141210215655
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Caffeine use is increasing worldwide. The underlying motivations are mainly concentration and memory enhancement and physical performance improvement. Coffee and caffeine-containing products affect the cardiovascular system, with their positive inotropic and chronotropic effects, and the central nervous system, with their locomotor activity stimulation and anxiogenic-like effects. Thus, it is of interest to examine whether these effects could be detrimental for health. Furthermore, caffeine abuse and dependence are becoming more and more common and can lead to caffeine intoxication, which puts individuals at risk for premature and unnatural death. The present review summarizes the main findings concerning caffeine's mechanisms of action (focusing on adenosine antagonism, intracellular calcium mobilization, and phosphodiesterases inhibition), use, abuse, dependence, intoxication, and lethal effects. It also suggests that the concepts of toxic and lethal doses are relative, since doses below the toxic and/or lethal range may play a causal role in intoxication or death. This could be due to caffeine's interaction with other substances or to the individuals' preexisting metabolism alterations or diseases.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 188 条
[81]  
Griffiths R.R., 1996, HDB EXPT PHARM, V118, P315
[82]  
GRIFFITHS RR, 1990, J PHARMACOL EXP THER, V255, P1123
[83]   CAFFEINE PHYSICAL-DEPENDENCE - A REVIEW OF HUMAN AND LABORATORY-ANIMAL STUDIES [J].
GRIFFITHS, RR ;
WOODSON, PP .
PSYCHOPHARMACOLOGY, 1988, 94 (04) :437-451
[84]   COFFEE, CAFFEINE, AND CARDIOVASCULAR-DISEASE IN MEN [J].
GROBBEE, DE ;
RIMM, EB ;
GIOVANNUCCI, E ;
COLDITZ, G ;
STAMPFER, M ;
WILLETT, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1026-1032
[85]   Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men [J].
Happonen, P ;
Voutilainen, S ;
Salonen, JT .
JOURNAL OF NUTRITION, 2004, 134 (09) :2381-2386
[86]   Cardiovascular effects of caffeine in men and women [J].
Hartley, TR ;
Lovallo, WR ;
Whitsett, TL .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08) :1022-1026
[87]   Coffee and health: A review of recent human research [J].
Higdon, JV ;
Frei, B .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2006, 46 (02) :101-123
[88]   THE EFFECT OF CAFFEINE ON EXERCISE TOLERANCE AND LEFT-VENTRICULAR FUNCTION IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
HIRSCH, AT ;
GERVINO, EV ;
NAKAO, S ;
COME, PC ;
SILVERMAN, KJ ;
GROSSMAN, W .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (08) :593-598
[89]   Caffeine fatalities -: four case reports [J].
Holmgren, P ;
Nordén-Pettersson, L ;
Ahlner, J .
FORENSIC SCIENCE INTERNATIONAL, 2004, 139 (01) :71-73
[90]  
HOLTZMAN SG, 1991, J PHARMACOL EXP THER, V256, P62